Your browser doesn't support javascript.
loading
89Zr-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake.
Moek, Kirsten L; Waaijer, Stijn J H; Kok, Iris C; Suurs, Frans V; Brouwers, Adrienne H; Menke-van der Houven van Oordt, C Willemien; Wind, Thijs T; Gietema, Jourik A; Schröder, Carolien P; Mahesh, Shekar V K; Jorritsma-Smit, Annelies; Lub-de Hooge, Marjolijn N; Fehrmann, Rudolf S N; de Groot, Derk Jan A; de Vries, Elisabeth G E.
Afiliação
  • Moek KL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Waaijer SJH; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Kok IC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Suurs FV; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Brouwers AH; Department of Radiology, Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Menke-van der Houven van Oordt CW; Department of Medical Oncology, VU University Medical Center, Amsterdam, the Netherlands.
  • Wind TT; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Gietema JA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Schröder CP; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Mahesh SVK; Department of Radiology, Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Jorritsma-Smit A; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Lub-de Hooge MN; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • de Groot DJA; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands. e.g.e.de.vries@umcg.nl.
Clin Cancer Res ; 25(12): 3517-3527, 2019 06 15.
Article em En | MEDLINE | ID: mdl-30745297
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos / Zircônio / Linfócitos T / Adenocarcinoma / Anticorpos Biespecíficos / Compostos Radiofarmacêuticos / Neoplasias Gastrointestinais Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Radioisótopos / Zircônio / Linfócitos T / Adenocarcinoma / Anticorpos Biespecíficos / Compostos Radiofarmacêuticos / Neoplasias Gastrointestinais Idioma: En Ano de publicação: 2019 Tipo de documento: Article